Published 2014
| Version v1.0.0
Journal Article
Open
Rituximab in Autoimmune CNS Disease
Creators
Abstract
Investigators at University of Sydney, Australia, and 14 international centers assessed the utility and safety of rituximab in 144 children (median age 8 years, range 0.7-17; 103 female) with autoimmune and inflammatory disorders of the CNS.Files
PNB-2014-28-8-7.pdf
Files
(99.9 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:cb52a58ea1d802f609ebc1651cd110cf
|
99.9 kB | Preview Download |
Additional details
Identifiers
- Other
- PNB-2014-28-8-7
Dates
- Created
-
2014When the item was originally created.